Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Advisory Committee to the Director, National Cancer Institute.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and meet special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Advisory Committee to the Director, National Cancer Institute.
Date: July 10, 2002.
Time: 1 p.m. to 3 p.m.
Agenda: The purpose of the meeting will be to discuss the Kidney/Bladder Progress Review Group Report.
Place: National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 31, Room 11A03, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Lisa Stevens, PhD, Executive Secretary, National Institute of Health, Building 31, Room 3A30, Bethesda, MD 20892, 301/496-1458.
Information is also available on the Institute's/Center home page: deainfo.nci.gov/advisory/joint/htm, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research, 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)Start Signature
Dated: June 11, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-15267 Filed 6-17-02; 8:45 am]
BILLING CODE 4140-01-M